Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity
- DOI
- 10.1016/j.bmc.2019.06.016
- Published
- 2019-08
- Container
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.bmc.2019.06.016,
title = {Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity},
author = {Yasunobu Yamashita and Ken-ichiro Tanaka and Naoki Yamakawa and Teita Asano and Yuki Kanda and Ayaka Takafuji and Masahiro Kawahara and Mitsuko Takenaga and Yoshifumi Fukunishi and Tohru Mizushima},
year = {2019},
journal = {Bioorganic \& Medicinal Chemistry},
doi = {10.1016/j.bmc.2019.06.016},
url = {https://doi.org/10.1016/j.bmc.2019.06.016}
}RIS
TY - JOUR TI - Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity AU - Yasunobu Yamashita AU - Ken-ichiro Tanaka AU - Naoki Yamakawa AU - Teita Asano AU - Yuki Kanda AU - Ayaka Takafuji AU - Masahiro Kawahara AU - Mitsuko Takenaga AU - Yoshifumi Fukunishi AU - Tohru Mizushima PY - 2019 JO - Bioorganic & Medicinal Chemistry DO - 10.1016/j.bmc.2019.06.016 UR - https://doi.org/10.1016/j.bmc.2019.06.016 ER -
APA
Yamashita, Y., Tanaka, K., Yamakawa, N., Asano, T., Kanda, Y., Takafuji, A., Kawahara, M., Takenaga, M., Fukunishi, Y., & Mizushima, T. (2019). Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/j.bmc.2019.06.016
Source records
- crossref · retrieved 2026-09-27T11:22:15.090Z